Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Avexis Inc (AVXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,020,501
  • Shares Outstanding, K 36,820
  • Annual Sales, $ 0 K
  • Annual Income, $ -218,050 K
  • 36-Month Beta 1.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.09
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12.34
  • Most Recent Earnings -2.55 on 02/27/18
  • Next Earnings Date 05/10/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate -2.10
  • Number of Estimates 4
  • High Estimate -1.30
  • Low Estimate -2.59
  • Prior Year -2.07
  • Growth Rate Est. (year over year) -1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
205.00 +6.31%
on 04/20/18
217.94 unch
on 05/15/18
+6.80 (+3.22%)
since 04/13/18
3-Month
112.93 +92.99%
on 02/20/18
217.94 unch
on 05/15/18
+101.83 (+87.70%)
since 02/15/18
52-Week
65.54 +232.53%
on 05/31/17
217.94 unch
on 05/15/18
+145.40 (+200.44%)
since 05/15/17

Most Recent Stories

More News
AVROBIO, Inc. Appoints Phillip B. Donenberg to its Board of Directors

AVROBIO, Inc. (NASDAQ:AVRO), a Phase 2 clinical stage gene therapy company focused on developing potentially curative lentiviral-based gene therapies to treat rare diseases following a single dose, today...

AVRO : 41.50 (+0.46%)
AVXS : 217.94 (+0.05%)
Novartis successfully completes acquisition of AveXis, Inc.

Novartis International AG / Novartis successfully completes acquisition of AveXis, Inc. . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this...

NVS : 85.03 (-0.12%)
AVXS : 217.94 (+0.05%)
Novartis completes tender offer for all outstanding shares of AveXis, Inc.

Novartis International AG / Novartis completes tender offer for all outstanding shares of AveXis, Inc. . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the...

NVS : 85.03 (-0.12%)
AVXS : 217.94 (+0.05%)
Options Traders Expect Huge Moves in AveXis (AVXS) Stock

AveXis (AVXS) needs investors to pay close attention to the stock based on moves in the options market lately.

AVXS : 217.94 (+0.05%)
Our Free Research Report on Biogen and More Biotech Stocks

Stock Research Monitor: AVXS, BHVN, and BMRN

BHVN : 36.91 (+2.93%)
AVXS : 217.94 (+0.05%)
Short Interest Declines 18.3% For AVXS

The most recent short interest data has been released for the 04/13/2018 settlement date, which shows a 681,577 share decrease in total short interest for AveXis Inc , to 3,040,624, a decrease of 18.31%...

AVXS : 217.94 (+0.05%)
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?

Style Box ETF report for JKJ

IJR : 88.73 (+0.28%)
JKJ : 183.67 (+0.36%)
LPLA : 64.12 (+0.06%)
FHN : 17.84 (-0.39%)
IWM : 170.27 (+0.42%)
AVXS : 217.94 (+0.05%)
AveXis Reports First Quarter 2018 Financial and Operating Results

-- Significant progress across operating functions including licensing, clinical trials and regulatory interactions --

AVXS : 217.94 (+0.05%)
Novartis provides update on proposed acquisition of AveXis

Novartis International AG / Novartis provides update on proposed acquisition of AveXis . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this...

NVS : 85.03 (-0.12%)
AVXS : 217.94 (+0.05%)
READ NOW: Monteverde & Associates PC Announces An Investigation Of AveXis, Inc. - AVXS

NEW YORK, NY / ACCESSWIRE / April 27, 2018 / , founder and managing partner at , a national securities firm headquartered at the Empire State Building in New York City, is investigating AveXis, Inc. ("AveXis"...

NVS : 85.03 (-0.12%)
AVXS : 217.94 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade AVXS with:

Business Summary

AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Company's product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant...

See More

Key Turning Points

2nd Resistance Point 218.06
1st Resistance Point 217.94
Last Price 217.94
1st Support Level 217.71
2nd Support Level 217.60

See More

52-Week High 217.94
Last Price 217.94
Fibonacci 61.8% 159.72
Fibonacci 50% 141.74
Fibonacci 38.2% 123.76
52-Week Low 65.54

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar